Skip to main content
Year archive

EMV CAPITAL PLC — 2022 filings

All 46 regulatory filings released by EMV CAPITAL PLC (EMVC) in 2022, sourced directly from the official regulator.

46 Filings
2022 Period
2022 filings (46)
Filing Released Lang
PDS Biotech: Median Overall Survival announcement
Regulatory Filings
2022-12-28 English
PDS: HPV16 Head and Neck Cancer announcement
Regulatory Filings
2022-12-16 English
Board Changes; Options; Co-Investment Agreement
Regulatory Filings
2022-12-12 English
EMV C leads £4.2m round in 5G and SATCOM leader
Regulatory Filings
2022-11-29 English
PDS Q3 Results and Business Update
Report Publication Announcement
2022-11-14 English
Second Price Monitoring Extn
Regulatory Filings
2022-11-14 English
Price Monitoring Extension
Regulatory Filings
2022-11-14 English
Board Change
Board/Management Information
2022-11-09 English
PDS reports presentation of data at cancer society
Regulatory Filings
2022-11-07 English
EMV Capital secures investment in Ventive
Regulatory Filings
2022-10-20 English
PDS Update
Regulatory Filings
2022-10-11 English
PDS completes End-of-Phase 2 meeting with FDA
Regulatory Filings
2022-10-03 English
Half-year Report
Interim / Quarterly Report H1 2022
2022-09-30 English
PDS Completes $35 Million Financing Agreement
Regulatory Filings
2022-08-25 English
Acquisition of 30% Vortex stake & new Vortex CEO
Regulatory Filings
2022-08-16 English
PDS Reports Q2 2022 Results & Business Update
Regulatory Filings
2022-08-08 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2022-06-29 English
Holding(s) in Company
Major Shareholding Notification
2022-06-28 English
Director/PDMR Shareholding
Director's Dealing
2022-06-27 English
Holding(s) in Company
Major Shareholding Notification
2022-06-27 English
Result of Placing and Total Voting Rights
Capital/Financing Update
2022-06-22 English
Proposed Placing to raise at least £1.5 million
Capital/Financing Update
2022-06-21 English
NetScientific to increase Q-Bot stake to 23.7%
Regulatory Filings
2022-06-17 English
Q-Bot secures £1.6m of investment to fund growth
Regulatory Filings
2022-06-15 English
Notice of AGM and Annual Report & Accounts
Report Publication Announcement
2022-06-07 English
PDS Granted FDA Fast Track Designation for PDS0101
Regulatory Filings
2022-06-06 English
PDS Biotech - new data for ongoing clinical trials
Regulatory Filings
2022-05-27 English
General Counsel Strategic Hire & Grant of Options
Regulatory Filings
2022-05-19 English
ProAxsis Update
Regulatory Filings
2022-05-16 English
Final Results
Audit Report / Information FY 2021
2022-05-12 English
PDS Reports Q1 2022 Results & Business Update
Earnings Release Q1 2022
2022-05-11 English
Notice of Results & Investor Presentation
Report Publication Announcement
2022-05-09 English
Acquisition of 30% of Vortex Biotech Holdings
M&A Activity
2022-05-06 English
Second Price Monitoring Extn
Regulatory Filings
2022-04-25 English
Price Monitoring Extension
Regulatory Filings
2022-04-25 English
Second Price Monitoring Extn
Regulatory Filings
2022-04-25 English
Price Monitoring Extension
Regulatory Filings
2022-04-25 English
PDS Provides Business Update & Full-Year Results
Earnings Release FY 2021
2022-03-31 English
Publication of Shareholder Newsletter
Report Publication Announcement
2022-03-04 English
PDS Announces Preliminary Safety Data on PDS0101
Regulatory Filings
2022-02-24 English
PDS Clinical Trial with Mayo Clinic
Regulatory Filings
2022-02-15 English
PDS Phase 2 Trial Update
Regulatory Filings
2022-02-02 English
PDS Announces Preclinical Data for PDS0202 Vaccine
Regulatory Filings
2022-01-28 English
Holding(s) in Company
Major Shareholding Notification
2022-01-18 English
PDS Granted Novel HPV16 Immunotherapy Patent
Regulatory Filings
2022-01-10 English
ProAxsis CEO End of Year Update
Regulatory Filings
2022-01-10 English